<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36810170</PMID><DateCompleted><Year>2023</Year><Month>02</Month><Day>24</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>09</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2044-6055</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>2</Issue><PubDate><Year>2023</Year><Month>Feb</Month><Day>21</Day></PubDate></JournalIssue><Title>BMJ open</Title><ISOAbbreviation>BMJ Open</ISOAbbreviation></Journal><ArticleTitle>Long COVID symptoms in Israeli children with and without a history of SARS-CoV-2 infection: a cross-sectional study.</ArticleTitle><Pagination><StartPage>e064155</StartPage><MedlinePgn>e064155</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e064155</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1136/bmjopen-2022-064155</ELocationID><Abstract><AbstractText Label="OBJECTIVES">To estimate the prevalence of long COVID symptoms in children with and without a history of SARS-CoV-2 infection and to evaluate factors associated with long COVID.</AbstractText><AbstractText Label="DESIGN">A nationwide cross-sectional study.</AbstractText><AbstractText Label="SETTING">Primary care.</AbstractText><AbstractText Label="PARTICIPANTS">3240 parents of children aged 5-18 with and without SARS-CoV-2 infection completed an online questionnaire (11.9% response rate); 1148 and 2092 with/without a history of infection, respectively.</AbstractText><AbstractText Label="PRIMARY AND SECONDARY OUTCOME MEASURES">Primary outcome was the prevalence of long COVID symptoms in children with/without a history of infection. Secondary outcomes were the factors associated with the presence of long COVID symptoms and with failure to return to baseline health status in children with a history of infection including gender, age, time from illness, symptomatic illness and vaccine status.</AbstractText><AbstractText Label="RESULTS">Most long COVID symptoms were more prevalent in children with a history of SARS-CoV-2 infection: headaches (211 (18.4%) vs 114 (5.4%), p&lt;0.001), weakness (173 (15.1%) vs 70 (3.3%), p&lt;0.001), fatigue (141 (12.3%) vs 133 (6.4%), p&lt;0.001) and abdominal pain (109 (9.5%) vs 79 (3.8%), p&lt;0.001). Most long COVID symptoms in children with a history of SARS-CoV-2 infection were more prevalent in the older age group (12-18) compared with the younger age group (5-11). Some symptoms were more prevalent in children without a history of SARS-CoV-2 infection, including attention problems with school malfunctioning (225 (10.8%) vs 98 (8.5%), p=0.05), stress (190 (9.1%) vs 65 (5.7%), p&lt;0.001), social problems (164 (7.8%) vs 32 (2.8%)) and weight changes (143 (6.8%) vs 43 (3.7%), p&lt;0.001).</AbstractText><AbstractText Label="CONCLUSION">This study suggests that the prevalence of long COVID symptoms in children with a history of SARS-CoV-2 infection might be higher and more prevalent in adolescents than in young children. Some of the symptoms, mainly somatic symptoms, were more prevalent in children without a history of SARS-CoV-2 infection, highlighting the impact of the pandemic itself rather than the infection.</AbstractText><CopyrightInformation>&#xa9; Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Adler</LastName><ForeName>Limor</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-9335-6596</Identifier><AffiliationInfo><Affiliation>Department of Family Medicine, Tel Aviv University Sackler Faculty of Medicine, Tel Aviv, Israel adler_l@mac.org.il.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Health Division, Maccabi Healthcare Services, Tel Aviv, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Israel</LastName><ForeName>Moran</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Health Division, Maccabi Healthcare Services, Tel Aviv, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yehoshua</LastName><ForeName>Ilan</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Health Division, Maccabi Healthcare Services, Tel Aviv, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Family Medicine, Ben-Gurion University of the Negev, Beer-Sheva, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Azuri</LastName><ForeName>Joseph</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Family Medicine, Tel Aviv University Sackler Faculty of Medicine, Tel Aviv, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Health Division, Maccabi Healthcare Services, Tel Aviv, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hoffman</LastName><ForeName>Robert</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-3053-835X</Identifier><AffiliationInfo><Affiliation>Department of Family Medicine, Tel Aviv University Sackler Faculty of Medicine, Tel Aviv, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Health Division, Maccabi Healthcare Services, Tel Aviv, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shahar</LastName><ForeName>Arnon</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Health Division, Maccabi Healthcare Services, Tel Aviv, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mizrahi Reuveni</LastName><ForeName>Miri</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Health Division, Maccabi Healthcare Services, Tel Aviv, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grossman</LastName><ForeName>Zachi</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Health Division, Maccabi Healthcare Services, Tel Aviv, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine, Ariel University, Ariel, Israel.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>02</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMJ Open</MedlineTA><NlmUniqueID>101552874</NlmUniqueID><ISSNLinking>2044-6055</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="Y">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007557" MajorTopicYN="N" Type="Geographic">Israel</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">EPIDEMIOLOGY</Keyword><Keyword MajorTopicYN="N">PAEDIATRICS</Keyword><Keyword MajorTopicYN="N">PRIMARY CARE</Keyword></KeywordList><CoiStatement>Competing interests: None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>22</Day><Hour>14</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>2</Month><Day>21</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36810170</ArticleId><ArticleId IdType="pmc">PMC9944622</ArticleId><ArticleId IdType="doi">10.1136/bmjopen-2022-064155</ArticleId><ArticleId IdType="pii">bmjopen-2022-064155</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>A clinical case definition of post COVID-19 condition by A delphi consensus. Available: https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1 [Accessed 4 Mar 2022].</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A, Bernabei R, Landi F. Gemelli against COVID-19 post-acute care study group. persistent symptoms in patients after acute COVID-19. JAMA 2020;324:603&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z, Xie Y, Bowe B. High-Dimensional characterization of post-acute sequelae of COVID-19. Nature 2021;594:259&#x2013;64. 10.1038/s41586-021-03553-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03553-9</ArticleId><ArticleId IdType="pubmed">33887749</ArticleId></ArticleIdList></Reference><Reference><Citation>Tenforde MW, Kim SS, Lindsell CJ, et al. . Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a multistate health care systems network-United States, march-june 2020. MMWR Morb Mortal Wkly Rep 2020;69:993&#x2013;8. 10.15585/mmwr.mm6930e1</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6930e1</ArticleId><ArticleId IdType="pmc">PMC7392393</ArticleId><ArticleId IdType="pubmed">32730238</ArticleId></ArticleIdList></Reference><Reference><Citation>Ludvigsson JF. Case report and systematic review suggest that children may experience similar long-term effects to adults after clinical COVID-19. Acta Paediatr 2021;110:914&#x2013;21. 10.1111/apa.15673</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apa.15673</ArticleId><ArticleId IdType="pmc">PMC7753397</ArticleId><ArticleId IdType="pubmed">33205450</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewis D. Long COVID and kids: scientists race to find answers. Nature 2021;595:482&#x2013;3. 10.1038/d41586-021-01935-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41586-021-01935-7</ArticleId><ArticleId IdType="pubmed">34262190</ArticleId></ArticleIdList></Reference><Reference><Citation>Behnood SA, Shafran R, Bennett SD, et al. . Persistent symptoms following SARS-cov-2 infection amongst children and young people: a meta-analysis of controlled and uncontrolled studies. J Infect 2022;84:158&#x2013;70. 10.1016/j.jinf.2021.11.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2021.11.011</ArticleId><ArticleId IdType="pmc">PMC8604800</ArticleId><ArticleId IdType="pubmed">34813820</ArticleId></ArticleIdList></Reference><Reference><Citation>Zavala M, Ireland G, Amin-Chowdhury Z, et al. . Acute and persistent symptoms in children with PCR-confirmed SARS-cov-2 infection compared to test-negative children in england: active, prospective, national surveillance. Clin Infect Dis 2021;75:e191&#x2013;200. 10.1093/cid/ciab991</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab991</ArticleId><ArticleId IdType="pmc">PMC8767867</ArticleId><ArticleId IdType="pubmed">34849658</ArticleId></ArticleIdList></Reference><Reference><Citation>Stephenson T, Pinto Pereira SM, Shafran R, et al. . Physical and mental health 3 months after SARS-cov-2 infection (long COVID) among adolescents in england (clock): a national matched cohort study. Lancet Child Adolesc Health 2022;6:230&#x2013;9. 10.1016/S2352-4642(22)00022-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(22)00022-0</ArticleId><ArticleId IdType="pmc">PMC8820961</ArticleId><ArticleId IdType="pubmed">35143770</ArticleId></ArticleIdList></Reference><Reference><Citation>Molteni E, Sudre CH, Canas LS, et al. . Illness duration and symptom profile in symptomatic UK school-aged children tested for SARS-cov-2. Lancet Child Adolesc Health 2021;5:708&#x2013;18. 10.1016/S2352-4642(21)00198-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(21)00198-X</ArticleId><ArticleId IdType="pmc">PMC8443448</ArticleId><ArticleId IdType="pubmed">34358472</ArticleId></ArticleIdList></Reference><Reference><Citation>Blankenburg J, Wekenborg MK, Reichert J, et al. . Comparison of mental health outcomes in seropositive and seronegative adolescents during the COVID19 pandemic. Sci Rep 2022;12:2246. 10.1038/s41598-022-06166-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-06166-y</ArticleId><ArticleId IdType="pmc">PMC8831534</ArticleId><ArticleId IdType="pubmed">35145161</ArticleId></ArticleIdList></Reference><Reference><Citation>Radtke T, Ulyte A, Puhan MA, et al. . Long-Term symptoms after SARS-cov-2 infection in children and adolescents. JAMA 2021;326:869&#x2013;71. 10.1001/jama.2021.11880</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.11880</ArticleId><ArticleId IdType="pmc">PMC8283661</ArticleId><ArticleId IdType="pubmed">34264266</ArticleId></ArticleIdList></Reference><Reference><Citation>Kikkenborg Berg S, Dam Nielsen S, Nygaard U, et al. . Long COVID symptoms in SARS-cov-2-positive adolescents and matched controls (longcovidkidsdk): a national, cross-sectional study. Lancet Child Adolesc Health 2022;6:240&#x2013;8. 10.1016/S2352-4642(22)00004-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(22)00004-9</ArticleId><ArticleId IdType="pmc">PMC8820960</ArticleId><ArticleId IdType="pubmed">35143771</ArticleId></ArticleIdList></Reference><Reference><Citation>Borch L, Holm M, Knudsen M, et al. . Long COVID symptoms and duration in SARS-cov-2 positive children-a nationwide cohort study. Eur J Pediatr 2022;181:1597&#x2013;607. 10.1007/s00431-021-04345-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00431-021-04345-z</ArticleId><ArticleId IdType="pmc">PMC8742700</ArticleId><ArticleId IdType="pubmed">35000003</ArticleId></ArticleIdList></Reference><Reference><Citation>Molteni E, Absoud M, Duncan EL. Assessing the impact of the pandemic in children and adolescents: SARS-cov-2 infection and beyond. Lancet Child Adolesc Health 2022;6:216&#x2013;7. 10.1016/S2352-4642(22)00035-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(22)00035-9</ArticleId><ArticleId IdType="pmc">PMC8820956</ArticleId><ArticleId IdType="pubmed">35143769</ArticleId></ArticleIdList></Reference><Reference><Citation>Michelen M, Manoharan L, Elkheir N, et al. . Characterising long COVID: a living systematic review. BMJ Glob Health 2021;6:e005427. 10.1136/bmjgh-2021-005427</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjgh-2021-005427</ArticleId><ArticleId IdType="pmc">PMC8478580</ArticleId><ArticleId IdType="pubmed">34580069</ArticleId></ArticleIdList></Reference><Reference><Citation>Long Q, Li J, Hu X, et al. . Follow-ups on persistent symptoms and pulmonary function among post-acute COVID-19 patients: a systematic review and meta-analysis. Front Med (Lausanne) 2021;8:702635. 10.3389/fmed.2021.702635</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.702635</ArticleId><ArticleId IdType="pmc">PMC8448290</ArticleId><ArticleId IdType="pubmed">34540862</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmad MS, Shaik RA, Ahmad RK, et al. . &#x201c; Long COVID&#x201d;: an insight. Eur Rev Med Pharmacol Sci 2021;25:5561&#x2013;77. 10.26355/eurrev_202109_26669</Citation><ArticleIdList><ArticleId IdType="doi">10.26355/eurrev_202109_26669</ArticleId><ArticleId IdType="pubmed">34533807</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S, Wegman-Ostrosky T, Perelman C, et al. . More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci Rep 2021;11:16144. 10.1038/s41598-021-95565-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-95565-8</ArticleId><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravens-Sieberer U, Kaman A, Erhart M, et al. . Quality of life and mental health in children and adolescents during the first year of the COVID-19 pandemic: results of a two-wave nationwide population-based study. Eur Child Adolesc Psychiatry 2021:1&#x2013;14. 10.1007/s00787-021-01889-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00787-021-01889-1</ArticleId><ArticleId IdType="pmc">PMC8506100</ArticleId><ArticleId IdType="pubmed">34636964</ArticleId></ArticleIdList></Reference><Reference><Citation>de Figueiredo CS, Sandre PC, Portugal LCL, et al. . COVID-19 pandemic impact on children and adolescents&#x2019; mental health: biological, environmental, and social factors. Prog Neuropsychopharmacol Biol Psychiatry 2021;106:110171. 10.1016/j.pnpbp.2020.110171</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pnpbp.2020.110171</ArticleId><ArticleId IdType="pmc">PMC7657035</ArticleId><ArticleId IdType="pubmed">33186638</ArticleId></ArticleIdList></Reference><Reference><Citation>Racine N, McArthur BA, Cooke JE, et al. . Global prevalence of depressive and anxiety symptoms in children and adolescents during COVID-19: a meta-analysis. JAMA Pediatr 2021;175:1142&#x2013;50. 10.1001/jamapediatrics.2021.2482</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapediatrics.2021.2482</ArticleId><ArticleId IdType="pmc">PMC8353576</ArticleId><ArticleId IdType="pubmed">34369987</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravens-Sieberer U, Kaman A, Otto C, et al. . Mental health and quality of life in children and adolescents during the COVID-19 pandemic-results of the copsy study. Dtsch Arztebl Int 2020;117:828&#x2013;9. 10.3238/arztebl.2020.0828</Citation><ArticleIdList><ArticleId IdType="doi">10.3238/arztebl.2020.0828</ArticleId><ArticleId IdType="pmc">PMC8005842</ArticleId><ArticleId IdType="pubmed">33568260</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong SJ. Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments. Infect Dis (Lond) 2021;53:737&#x2013;54. 10.1080/23744235.2021.1924397</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23744235.2021.1924397</ArticleId><ArticleId IdType="pmc">PMC8146298</ArticleId><ArticleId IdType="pubmed">34024217</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y, Pinto MD, Borelli JL, et al. . COVID symptoms, symptom clusters, and predictors for becoming a long-hauler looking for clarity in the haze of the pandemic. Clin Nurs Res 2022;31:1390&#x2013;8. 10.1177/10547738221125632</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/10547738221125632</ArticleId><ArticleId IdType="pmc">PMC9510954</ArticleId><ArticleId IdType="pubmed">36154716</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai F, Tomasoni D, Falcinella C, et al. . Female gender is associated with long COVID syndrome: a prospective cohort study. Clin Microbiol Infect 2022;28:611. 10.1016/j.cmi.2021.11.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2021.11.002</ArticleId><ArticleId IdType="pmc">PMC8575536</ArticleId><ArticleId IdType="pubmed">34763058</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>